Challenges and prospects for malaria elimination in the Greater Mekong Subregion

Acta Tropica

Volumn 121, Issue 3, 2012, Pages 240-245

  Cui, Liwang ^a,d   Yan, Guiyun ^b,d   Sattabongkot, Jetsumon ^c   Chen, Bin ^d   Cao, Yaming ^e   Fan, Qi ^f   Parker, Daniel ^a   Sirichaisinthop, Jeeraphat ^g   Su, Xin zhuan ^h   Yang, Henglin ⁱ   Yang, Zhaoqing ^j   Wang, Baomin ^k   Zhou, Guofa ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^d CHONGQING NORMAL UNIVERSITY   (China)

^e CHINA MEDICAL UNIVERSITY   (China)

^f Dalian Institute of Biotechnology   (China)

^g Vector Borne Disease Training Center   (Thailand)

^h NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

ⁱ Yunnan Institute of Parasitic Diseases   (China)

^j KUNMING MEDICAL UNIVERSITY   (China)

^k CHINA AGRICULTURAL UNIVERSITY   (China)

more..

Author keywords

Counterfeit drugs; Drug resistance; Epidemiology; Malaria; The Greater Mekong Subregion; Vector systems

Indexed keywords

ARTEMISIN;

DISEASE CONTROL; DISEASE TRANSMISSION; DRUG RESISTANCE; EPIDEMIOLOGY; MALARIA;

ANIMAL BEHAVIOR; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CAMBODIA; CHINA; DISEASE SURVEILLANCE; DRUG EFFICACY; DRUG SURVEILLANCE PROGRAM; GEOGRAPHIC DISTRIBUTION; HABITAT STRUCTURE; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; INSECT BITE; LAOS; MALARIA; MALARIA CONTROL; MYANMAR; NONHUMAN; PARASITE INCIDENCE; PARASITE TRANSMISSION; PARASITE VECTOR; THAILAND; VECTOR CONTROL; VIET NAM;

ANIMALS; ANTIMALARIALS; ARTEMISININS; ASIA, SOUTHEASTERN; DISEASE ERADICATION; DRUG RESISTANCE; HUMANS; INSECT VECTORS; INSECTICIDES; MALARIA, FALCIPARUM; NATIONAL HEALTH PROGRAMS; PLASMODIUM FALCIPARUM; RESEARCH;

PLASMODIUM FALCIPARUM;

EID: 84857648447     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2011.04.006     Document Type: Article

References (29)

1. Atemnkeng M.A., De Cock K., Plaizier-Vercammen J. Quality control of active ingredients in artemisinin-derivative antimalarials within Kenya and DR Congo. Trop. Med. Int. Health 2007, 12:68-74.
2. Bosman A., Mendis K.N. A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies. Am. J. Trop. Med. Hyg. 2007, 77:193-197.
3. Carrara V.I., Zwang J., Ashley E.A., Price R.N., Stepniewska K., Barends M., Brockman A., Anderson T., McGready R., Phaiphun L., Proux S., van Vugt M., Hutagalung R., Lwin K.M., Phyo A.P., Preechapornkul P., Imwong M., Pukrittayakamee S., Singhasivanon P., White N.J., Nosten F. Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoS One 2009, 4:e4551.
4. Dondorp A.M., Nosten F., Yi P., Das D., Phyo A.P., Tarning J., Lwin K.M., Ariey F., Hanpithakpong W., Lee S.J., Ringwald P., Silamut K., Imwong M., Chotivanich K., Lim P., Herdman T., An S.S., Yeung S., Singhasivanon P., Day N.P., Lindegardh N., Socheat D., White N.J. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 2009, 361:455-467.
5. Dondorp A.M., Yeung S., White L., Nguon C., Day N.P., Socheat D., von Seidlein L. Artemisinin resistance: current status and scenarios for containment. Nat. Rev. 2010, 8:272-280.
6. Feachem R.G., Phillips A.A., Hwang J., Cotter C., Wielgosz B., Greenwood B.M., Sabot O., Rodriguez M.H., Abeyasinghe R.R., Ghebreyesus T.A., Snow R.W. Shrinking the malaria map: progress and prospects. Lancet 2010, 376:1566-1578.
7. Guthmann J.P., Pittet A., Lesage A., Imwong M., Lindegardh N., Min Lwin M., Zaw T., Annerberg A., de Radiguès X., Nosten F. Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar. Trop. Med. Int. Health 2008, 13:91-98.
8. Hu H., Singhasivanon P., Salazar N.P., Thimasarn K., Li X., Wu Y., Yang H., Zhu D., Supavej S., Looarecsuwan S. Factors influencing malaria endemicity in Yunnan Province PR China (analysis of spatial pattern by GIS). Geographical Information System. Southeast Asian J. Trop. Med. Public Health. 1998, 29:191-200.
9. Krudsood S., Wilairatana P., Mason D.P., Treeprasertsuk S., Singhasivanon P., Looareesuwan S. Hidden Plasmodium falciparum infections. Southeast Asian J. Trop. Med. Public Health 1999, 30:623-624.
10. Marlar-Than, Myat-Phone-Kyaw, Aye-Yu-Soe, Khaing-Khaing-Gyi, Ma-Sabai, Myint-Oo Development of resistance to chloroquine by Plasmodium vivax in Myanmar. Trans. R. Soc. Trop. Med. Hyg. 1995, 89:307-308.
11. Mayxay M., Pukritrayakamee S., Chotivanich K., Imwong M., Looareesuwan S., White N.J. Identification of cryptic coinfection with Plasmodium falciparum in patients presenting with vivax malaria. Am. J. Trop. Med. Hyg. 2001, 65:588-592.
12. Myat-Phone-Kyaw, Myint-Oo, Myint-Lwin, Thaw-Zin, Kyin-Hla-Aye, Nwe-Nwe-Yin Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma). Trans. R. Soc. Trop. Med. Hyg. 1993, 87:687.
13. Ministry of Health of China The People's Republic of China - From Malaria Control to Elimination: A Revised National Malaria Strategy 2009, ftp://ftp.wpro.who.int/scratch/R10%20Submitted%20Proposals/CHN/Malaria/R10%20Annexes%201-10/Annex%205%20China%20National%20Malaria%20Strategy%20(2010-2015).doc.
14. Mu J., Myers R.A., Jiang H., Liu S., Ricklefs S., Waisberg M., Chotivanich K., Udomsangpetch R., Sattabongkot J., Cui L., Ho M., Ou F.Z., Li H., Song J., Li G., Wang X., Seila S., Sokunthea S., Socheat D., Porcella S., Fairhurst R., Wellems T.E., Awadalla P., Su X. Genome-wide positive selection, recombination hotspots, and loci associated with Plasmodium falciparum resistance to antimalarial drugs. Nat. Genet. 2009, 42:268-271.
15. Na-Bangchang K., Ruengweerayut R., Mahamad P., Ruengweerayut K., Chaijaroenkul W. Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border. Malar. J. 2010, 9:273.
16. Newton P., Proux S., Green M., Smithuis F., Rozendaal J., Prakongpan S., Chotivanich K., Mayxay M., Looareesuwan S., Farrar J., Nosten F., White N.J. Fake artesunate in southeast Asia. Lancet 2001, 357:1948-1950.
17. Newton P.N., Dondorp A., Green M., Mayxay M., White N.J. Counterfeit artesunate antimalarials in southeast Asia. Lancet 2003, 362:169.
18. Newton P.N., McGready R., Fernandez F., Green M.D., Sunjio M., Bruneton C., Phanouvong S., Millet P., Whitty C.J., Talisuna A.O., Proux S., Christophel E.M., Malenga G., Singhasivanon P., Bojang K., Kaur H., Palmer K., Day N.P., Greenwood B.M., Nosten F., White N.J. Manslaughter by fake artesunate in Asia - will Africa be next?. PLoS Med. 2006, 3:e197.
19. Noedl H., Se Y., Schaecher K., Smith B.L., Socheat D., Fukuda M.M. Evidence of artemisinin-resistant malaria in western Cambodia. N. Engl. J. Med. 2008, 359:2619-2620.
20. Noedl H., Socheat D., Satimai W. Artemisinin-resistant malaria in Asia. N. Engl. J. Med. 2009, 361:540-541.
21. Rogers W.O., Sem R., Tero T., Chim P., Lim P., Muth S., Socheat D., Ariey F., Wongsrichanalai C. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Malar. J. 2009, 8:10.
22. Socheat D., Denis M.B., Fandeur T., Zhang Z., Yang H., Xu J., Zhou X., Phompida S., Phetsouvanh R., Lwin S., Lin K., Win T., Than S.W., Htut Y., Prajakwong S., Rojanawatsirivet C., Tipmontree R., Vijaykadga S., Konchom S., Cong le D., Thien N.T., Thuan le K., Ringwald P., Schapira A., Christophel E., Palmer K., Arbani P.R., Prasittisuk C., Rastogi R., Monti F., Urbani C., Tsuyuoka R., Hoyer S., Otega L., Thimasarn K., Songcharoen S., Meert J.P., Gay F., Crissman L., Cho Min N., Chansuda W., Darasri D., Indaratna K., Singhasivanon P., Chuprapawan S., Looareesuwan S., Supavej S., Kidson C., Baimai V., Yimsamran S., Buchachart K. Mekong malaria II. Update of malaria, multi-drug resistance and economic development in the Mekong region of Southeast Asia. Southeast Asian J. Trop. Med. Public Health 2003, 34(Suppl. 4):1-102.
23. Tatem A.J., Smith D.L., Gething P.W., Kabaria C.W., Snow R.W., Hay S.I. Ranking of elimination feasibility between malaria-endemic countries. Lancet 2010, 376:1579-1591.
24. WHO Malaria in the Greater Mekong Subregion: Regional and Country Profiles 2008, p. 59, http://www.whothailand.org/EN/Section3/section113.htm.
25. WHO Global Plan for Artemisinin Resistance Containment (GPARC) 2011, p. 87.
26. Wiwanitkit V. Genetic disorders and malaria in Indo-China region. J. Vector Borne Dis. 2008, 45:98-104.
27. Wongsrichanalai C., Arevalo I., Laoboonchai A., Yingyuen K., Miller R.S., Magill A.J., Forney J.R., Gasser R.A. Rapid diagnostic devices for malaria: field evaluation of a new prototype immunochromatographic assay for the detection of Plasmodium falciparum and non-falciparum Plasmodium. Am. J. Trop. Med. Hyg. 2003, 69:26-30.
28. Wongsrichanalai C., Meshnick S.R. Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border. Emerg. Infect. Dis. 2008, 14:716-719.
29. Yang H., Liu D., Yang Y., Fan B., Yang P., Li X., Li C., Dong Y., Yang C. Changes in susceptibility of Plasmodium falciparum to artesunate in vitro in Yunnan Province, China. Trans. R. Soc. Trop. Med. Hyg. 2003, 97:226-228.